Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

Almost All Of World's Children Exposed to Climate Hazards, UN Agency Says

Almost all of the world's children are exposed to at least one climate hazard, with as many as 1.8 ⁠billion put in danger by droughts and 1.2 billion by extreme heat, the...

AMA Survey: More Doctors Are Embracing AI-Based Tools

More than 80% of respondents say they use AI in their practices, but what that means isn’t always clear.

Functional Neurologic Disorders: Are Signs Being Missed?

Experts encourage earlier recognition of characteristic symptom patterns as prolonged diagnostic delays may worsen recovery and quality of life.

Professional Corner: CPR at World Cup, AMA Leader, More

The American Heart Association brings CPR to the World Cup, American Medical Association names president-elect, and American College of Physicians seeks private equity oversight.

Baby Formula Maker Nara Issues US-wide Recall After FDA, CDC Flag Infant Botulism Cases

Baby formula maker Nara Organics said it is voluntarily recalling all of its infant formula, currently ⁠available in the United States, over potential risk of bacterial...

Suicidality Affects 11% Youth After Sexual Abuse Assessment

Among youth ages 10-17 years evaluated for sexual abuse, more than 11% experienced suicidality within 90 days, with nearly 22% of those attempting suicide.

Todays Updates

Multiple Myeloma Patients Have Unequal Access to Treatment

Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.

Combination Treatment May Improve Multiple Myeloma Outcomes

Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.

Is There a Role for Stimulants in Beating Cancer Fatigue?

Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.

Todays Updates

Multiple Myeloma Patients Have Unequal Access to Treatment

Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.

Combination Treatment May Improve Multiple Myeloma Outcomes

Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.

Is There a Role for Stimulants in Beating Cancer Fatigue?

Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.

Latest News

Almost all of the world's children are exposed to at least one climate hazard, with as many as 1.8 ⁠billion put in danger by droughts and 1.2 billion by extreme heat, the...

More than 80% of respondents say they use AI in their practices, but what that means isn’t always clear.

Experts encourage earlier recognition of characteristic symptom patterns as prolonged diagnostic delays may worsen recovery and quality of life.

The American Heart Association brings CPR to the World Cup, American Medical Association names president-elect, and American College of Physicians seeks private equity oversight.

Baby formula maker Nara Organics said it is voluntarily recalling all of its infant formula, currently ⁠available in the United States, over potential risk of bacterial...

Among youth ages 10-17 years evaluated for sexual abuse, more than 11% experienced suicidality within 90 days, with nearly 22% of those attempting suicide.

News All Time

Pediatric Ketamine Sedation Not Tied to Serious AEs

Children receiving ketamine sedation in the ED rarely have serious side effects, but risks are slightly higher in those who are older, those with respiratory infections, or those receiving opioids.

NICE Recommends Mepolizumab for Uncontrolled COPD

Mepolizumab is the second biologic approved for eosinophilic COPD this year, joining dupilumab in offering an alternative to triple therapy alone.

Diabetic Ketoacidosis Diagnosed Beyond Lab Criteria

Not all patients in the emergency department diagnosed with diabetic ketoacidosis meet laboratory criteria; a study shows that physicians rely on clinical signs and symptoms.

Older Age Tied to Higher CT Positivity in Abdominal Pain

Older adults visiting the emergency department for abdominal pain have higher risks for CT positivity and hospital admission than younger adults, despite less specific symptoms.

Texas Firearm Injuries: ED Admits Up, Costs Nearly Double

Firearm injuries continue to strain Texas emergency departments, with increasing hospitalizations and nearly doubled charges underscoring the growing burden on healthcare systems and communities.

AI Decision Support in ED: Helpful Tool or Clinical Risk?

Research shows artificial intelligence has use in the emergency department, but how it’s implemented is key.

Australian Doctors Lukewarm on Latest Federal Budget

Australia's latest federal budget includes $25 billion extra for public hospitals but offers little new support for general practitioners and rural healthcare.

Spain’s Debate Over Obstetric Violence

Health leaders in Spain debate balancing maternal-fetal safety with respectful, informed care, spotlighting birth plans, staffing shortages and calls for public outcome reporting.

Adjunctive Tirofiban Gains Ground in Stroke

Three major studies suggest intravenous or intra-arterial tirofiban may improve reperfusion outcomes without excess safety risk in selected patients with acute ischemic stroke.

Nestle and Danone Face Fresh Scrutiny Over Infant Formula Recalls

Nestle and Danone are facing fresh scrutiny over the handling of infant formula contamination after reports published on Tuesday by French, Belgian and Swiss public ⁠media...

Spanish Authorities Say Homeopathy Is No Better Than Placebo

Authorities report that stronger trial methodology consistently reduces the apparent benefits linked to homeopathic products across conditions.

Declare Climate Change a Public Health Emergency, EU Experts

A European report says the WHO should urgently scale up climate and health action in the face of waning attention.

Certain Gut-Brain Symptoms Transcend Anatomic Divisions

An expanded symptom questionnaire identified 10 gastrointestinal symptom clusters in patients with disorders of gut-brain interaction.

Ebola Deaths in Eastern Congo Rise to 131, WHO Voices Deep Concern

Twenty-six more suspected Ebola deaths were recorded in 24 hours in eastern Democratic Republic of Congo, authorities said on Tuesday, and the head of the World Health...

Cosmetic-Related Eye Injuries in Kids Up Since 2020

Pediatric eye injuries related to use of cosmetics rose 5.6% from 2020 to 2024, with toddlers most commonly affected and teens showing the largest increases, a new study finds.

Can Rise of Direct Primary Care Ease Hospital Admissions?

Research has shown direct care may reduce emergency department visit and hospital use, but questions remain about equity.

Recommended News For You

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

Higher levels of HIF2α found to slow down aggressive childhood cancer

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

New analysis helps discern benign from malignant thyroid growths

Lesser-known lobular breast cancer on the rise in U.S. women

Childhood brain tumors develop early in highly specialized nerve cells, research reveals

Recommended Articles For You

Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion 

Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment 

Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies 

Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone

2.

Survey: Record Numbers of US Adults Report Depression.

3.

Increased Exercise May Lower the Risk of Prostate Cancer.

4.

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

5.

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

1.

Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment

2.

A Review of Cancer Treatment Evolution Towards Stem Cells and Gene Therapy

3.

The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy

4.

Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies

5.

HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Current Scenario of Cancer- The Incidence of Cancer in Men

2.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

4.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

5.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot